ACM

Aisling Capital Management Portfolio holdings

AUM $360M
This Quarter Return
-23.04%
1 Year Return
+114.67%
3 Year Return
+1,171.46%
5 Year Return
+892.24%
10 Year Return
–
AUM
$94.9M
AUM Growth
–
Cap. Flow
+$94.9M
Cap. Flow %
100%
Top 10 Hldgs %
96.07%
Holding
12
New
12
Increased
–
Reduced
–
Closed
–

Top Buys

1
OBSV
ObsEva SA Ordinary Shares
OBSV
$17.6M
2
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
$15.5M
3
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
$12.3M
4
MRKR icon
Marker Therapeutics
MRKR
$11.1M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$10.2M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
OBSV
1
DELISTED
ObsEva SA Ordinary Shares
OBSV
$17.6M 18.49%
+1,386,338
New +$17.6M
EIDX
2
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$15.5M 16.29%
+1,123,630
New +$15.5M
TECX
3
Tectonic Therapeutic, Inc. Common Stock
TECX
$312M
$12.3M 12.93%
+736,998
New +$12.3M
MRKR icon
4
Marker Therapeutics
MRKR
$11.6M
$11.1M 11.69%
+2,000,000
New +$11.1M
BHVN
5
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$10.2M 10.69%
+274,513
New +$10.2M
SYRE icon
6
Spyre Therapeutics
SYRE
$996M
$6.51M 6.85%
+868,621
New +$6.51M
RCUS icon
7
Arcus Biosciences
RCUS
$1.13B
$5.78M 6.09%
+536,513
New +$5.78M
ACRS icon
8
Aclaris Therapeutics
ACRS
$209M
$4.69M 4.94%
+634,455
New +$4.69M
VRNA
9
Verona Pharma
VRNA
$9.16B
$4.28M 4.51%
+443,596
New +$4.28M
ZSAN
10
DELISTED
Zosano Pharma Corporation
ZSAN
$3.39M 3.57%
+1,600,000
New +$3.39M
NBRV
11
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$2.64M 2.78%
+1,809,259
New +$2.64M
VIRX
12
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.09M 1.15%
+2,600,000
New +$1.09M